News | November 08, 2010

Report Gives New Insights for Improving Cardiac Care

November 8, 2010 – The American College of Cardiology (ACC) and American Heart Association (AHA) issued a joint report outlining new performance measures in cardiac care. The full report will be published in the Nov. 16 issue of the Journal of the American College of Cardiology.

“As performance measures have grown in importance, we must constantly be sure that they are created in the most sound scientific manner so that the goal of using these measures – to improve care – are most likely to be achieved,” said John A Spertus, M.D., MPH Daniel Lauer/Missouri Endowed Chair and professor, University of Missouri Kansas City and chair of the 12-person writing committee. “This document provides guidance to the creators of performance measures so that they can create the most useful measures to improve the quality of care.”

The inherent delay between the collection of new evidence and its adoption into routine care means performance measures do not always take emerging evidence into account. The updated report addresses this issue and ensures that only the processes of care associated with the strongest evidence and meaningful outcomes are endorsed, Spertus said.

“Professional societies have learned a lot about new challenges and opportunities since the original recommendations for the methodology of performance measure development were written five years ago,” he said. “Since performance measures, once developed, almost always become mandatory clinical actions, it is very important that the issues raised in this paper be considered so that adverse consequences can be avoided.”

Currently, performance measures are more often used as tools for accountability and reimbursement. Initially, they were intended to help physicians improve the quality of care and patient outcomes.

“As we use performance measures, we have learned how to make them more accurate, meaningful and actionable,” Spertus said. “Recently, insurers are starting to pay more for practices that more often comply with performance measures and major payers, such as Medicare, are increasingly publishing providers’ performance for the public to review.”

For more information: www.cardiosource.org

Related Content

Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Study Discovers Anticoagulant Drugs Are Being Prescribed Against Safety Advice
News | Antiplatelet and Anticoagulation Therapies| July 25, 2017
July 25, 2017 — A study by researchers at the University of Birmingham has shown that general practitioners (GPs) are
CareSelect Declared Fully Qualified Clinical Decision Support Mechanism by CMS
News | Clinical Decision Support| July 18, 2017
National Decision Support Company announced the full qualification of its CareSelect Platform as a Qualified Clinical...
CMS Proposes Delaying Clinical Decision Support Documentation to 2019
News | Clinical Decision Support| July 14, 2017 | Jeff Zagoudis, Associate Editor
In a series of proposed rule changes to the Medicare Physician Fee Schedule (MPFS) released July 13, the Centers for...
long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies| July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet ther
Sex-Specific Cardiovascular Drug Dosages Needed to Reduce Adverse Reactions in Women
News | Womens Healthcare| July 07, 2017
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper...
Bayer Now Enrolling Patients for Global Pulmonary Arterial Hypertension Study
News | Hypertension| July 05, 2017
Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of riociguat in patients...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
FDA Grants Priority Review of Xarelto sNDA for 10 mg Dose
News | Antiplatelet and Anticoagulation Therapies| June 29, 2017
Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) accepted for Priority...
radial access, transradial access trial using anticoagulants
News | Radial Access| June 15, 2017
June 15, 2017 — In patients undergoing t...
Overlay Init